CAPRICOR THERAPEUTICS, INC. short interest in 2019
In 2019, CAPRICOR THERAPEUTICS, INC.'s disclosed short interest ran from 2.71% of shares outstanding on 15 Jan 2019 to 0.65% on 31 Dec 2019, a change of -2.06 percentage points. The year's high was 3.32% on 15 Oct 2019 and its low 0.65% on 31 Dec 2019, averaging 1.75% across 18 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 8.73 days on 15 Jan 2019. Full history: CAPRICOR THERAPEUTICS, INC..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2019 in figures
- Start of year
- 2.71% (15 Jan 2019)
- End of year
- 0.65% (31 Dec 2019)
- Change
- -2.06 pp
- High
- 3.32% (15 Oct 2019)
- Low
- 0.65% (31 Dec 2019)
- Average
- 1.75%
- Highest days to cover
- 8.73 (15 Jan 2019)
- SEC filings marked
- 8
Every report in 2019
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2019 | 2.71% | 8.73 | |
| 31 Jan 2019 | 2.39% | 1.00 | |
| 15 Feb 2019 | 2.18% | 3.92 | |
| 28 Feb 2019 | 2.02% | 5.90 | |
| 15 Mar 2019 | 1.90% | 3.74 | |
| 29 Mar 2019 | 1.64% | 2.23 | results (8-K), 10-K filed |
| 15 Apr 2019 | 0.86% | 1.00 | |
| 30 Apr 2019 | 1.14% | 3.69 | |
| 15 May 2019 | 1.04% | 2.09 | results (8-K), 10-Q filed |
| 31 May 2019 | 0.97% | 1.00 | |
| 15 Aug 2019 | 1.99% | 1.00 | results (8-K), 10-Q filed |
| 30 Aug 2019 | 1.66% | 1.00 | |
| 13 Sep 2019 | 1.55% | 1.27 | |
| 15 Oct 2019 | 3.32% | 1.00 | |
| 31 Oct 2019 | 2.35% | 1.92 | |
| 15 Nov 2019 | 1.63% | 1.28 | results (8-K), 10-Q filed |
| 29 Nov 2019 | 1.58% | 2.40 | |
| 31 Dec 2019 | 0.65% | 1.00 |
See also: CAPRICOR THERAPEUTICS, INC.'s full history · most shorted US stocks of 2019 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.